Valencell Expands Intellectual Property Portfolio with Critical Patents Enabling Highly Accurate Biometric Fitness and Health Assessments

12 patents granted in 2015 brings Company's global portfolio of highly-cited patents to 29

Nov 23, 2015, 08:30 ET from Valencell

RALEIGH, N.C., Nov. 23, 2015 /PRNewswire/ -- Valencell, a leader in biometric data sensor technology, today announced it has been granted 12 new patents in 2015 in the US, Europe, and Japan, expanding the Company's intellectual property portfolio to 29. Valencell's patent portfolio is the most highly-cited patent portfolio in wearable biometrics and the Company has more than 60 additional patents pending. The new patents recognize advancements in motion-tolerant biometric sensor technology that enable wearable devices to deliver insightful fitness and health assessments.

Valencell PerformTek sensor technology gives wearable devices the ability to continuously and accurately measure weak blood flow signals even during extreme physical activity. These signals are translated into biometric data, including continuous heart rate, VO2 and VO2 max, resting heart rate, heart rate response, heart rate recovery, continuous energy expenditure (calorie burn), cardiac efficiency and heart rate variability. When measured accurately, these metrics have been scientifically proven to provide insights into a person's fitness and health, as outlined in a recent Valencell blog post. The accuracy of Valencell's technology is what makes it stand out from other options and enables the data to be applicable to health assessments.

"Over the past two decades, numerous fitness and health assessments have been developed and validated by researchers across the world, but the big challenge has been getting accurate biometric information into these models through devices that consumers already wear. Our team of expert biometric engineers and exercise scientists have dedicated their careers to developing the most advanced wearable optomechanical biometric sensor technology in the world," said Dr. Steven LeBoeuf, president and co-founder of Valencell. "These new patents further illustrate our technology's ability to track key biometric measurements in wearables of all shapes and sizes with the accuracy needed to make real health assessments."

The 12 patents granted include:

  • U.S. Pat. No. 9.131,312, "Physiological monitoring methods"
  • U.S. Pat. No. D736,935, "Biometric monitor housing"
  • U.S. Pat. No. D733.598, "Biometric monitor"
  • U.S. Pat. No. 9,044,180, "Noninvasive physiological analysis using excitation-sensor modules and related devices and methods"
  • U.S. Pat. No. 8,989,830, "Wearable light-guiding devices for physiological monitoring"
  • U.S. Pat. No. 8,961,415, "Methods and apparatus for assessing physiological conditions"
  • U.S. Pat. No. 8,942,776, "Physiological monitoring methods"
  • U.S. Pat. No. 8,934,952, "Wearable monitoring devices having sensors and light guides"
  • U.S. Pat. No. 8,929,966, "Physiological monitoring methods"
  • U.S. Pat. No. 8,929,965, "Light-guiding devices and monitoring devices"
  • European Patent Number 002684001-0001
  • Japan Patent Number 5,789,199

Valencell PerformTek Technology has been licensed by leading brands such as Sony, Intel, LG, Scosche, and Jabra, among numerous others. PerformTek is the only technology available that continuously measures heart rate, VO2, calories burned, cadence with scientifically-validated accuracy. To learn more about licensing Valencell technology, visit

About Valencell
Valencell develops performance biometric sensor technology and licenses this patent-protected technology to consumer electronics manufacturers, mobile device and accessory makers, sports and fitness brands and gaming companies for integration into their products. Valencell's PerformTek-powered sensors are the most accurate wearable biometric sensors that continuously measure activity, heart rate, and numerous PPG-based biometrics. Valencell has invested years into the research and development of its PerformTek sensor technology, protected by dozens of granted patents and independently validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine.

SOURCE Valencell